CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

SCDWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D007239 Infection NIH 0.05

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 A Multi-Center Pilot Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Patients Developing Acute Kidney Injury (AKI) or Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 Infection

Selective Cytopheretic Device (SCD) treatments will improve survival in patients testing positive for COVID-19 infection diagnosed with Acute Kidney Injury (AKI) or ARDS.

NCT04395911 AKI ARDS COVID Device: SCD
MeSH:Infection

Primary Outcomes

Description: All cause mortality at Day 60

Measure: Mortality at Day 60

Time: 60 days post treatment

Description: Dialysis Dependency at Day 60

Measure: Dialysis Dependency

Time: 60 days post treatment

Description: Ventilation free survival at Day 28

Measure: Ventilation at Day 28

Time: 28 days post treatment

Secondary Outcomes

Description: Dialysis Dependency at Day 28

Measure: Dialysis Dependency

Time: 28 days post treatment

Description: All cause mortality at Day 28

Measure: Mortality at Day 28

Time: 28 days post treatment

Description: Change from baseline in urine output

Measure: Urinary output change

Time: 10 days of treatment

Description: Change from baseline in PO2/FiO2

Measure: P02/FiO2 change

Time: 10 days of treatment

Description: Assessment of SAEs, AE and UADEs

Measure: Safety Assessments

Time: 10 days of treatment

Description: Assessment of device performance

Measure: SCD Integrity

Time: 10 days of treatment

No related HPO nodes (Using clinical trials)